TAM
TFG Asset Management Portfolio holdings
AUM
$474M
1-Year Est. Return
47.87%
This Fund
S&P 500
1 Year Est. Return
+47.87%
AUM
$689M
AUM Growth
+$134M
(+24%)
Holding
48
Top Buys
| 1 | +$38.2M | |
| 2 | +$2.38M | |
| 3 | +$2.09M | |
| 4 |
ABVX
Abivax
ABVX
|
+$1.84M |
| 5 |
Arrowhead Research
ARWR
|
+$1.8M |
Top Sells
| 1 | +$6.15M | |
| 2 | +$1.81M | |
| 3 | +$1.78M | |
| 4 |
Annexon
ANNX
|
+$1.73M |
| 5 |
Keros Therapeutics
KROS
|
+$1.26M |
Sector Composition
| 1 | Technology | 40.8% |
| 2 | Healthcare | 11.98% |
| 3 | Energy | 6.01% |
| 4 | Materials | 0.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
UiPath
PATH
$5.74B
| $227M | 32.93% |
16,950,000
+3,227,756
|
|
||
|
KGEI
2
Kolibri Global Energy
KGEI
$135M
| $39.2M | 5.69% |
7,070,568
+1,711
|
|
||
3
Lyft
LYFT
$5.51B
| $22M | 3.2% |
1,000,000
|
|
||
4
Sprinklr
CXM
$1.44B
| $17M | 2.47% |
2,200,000
|
|
||
|
AUTL
5
Autolus Therapeutics
AUTL
$455M
| $15.5M | 2.25% |
9,500,000
|
|
||
6
Workiva
WK
$3.46B
| $12.9M | 1.88% |
150,000
|
|
||
7
Celldex Therapeutics
CLDX
$2B
| $7.85M | 1.14% |
303,600
-12,550
|
|
||
8
Tarsus Pharmaceuticals
TARS
$3.21B
| $7.43M | 1.08% |
125,000
-125,000
|
|
||
|
9
Annexon
ANNX
$835M
| $6.44M | 0.94% |
2,112,455
-697,545
|
|
||
10
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.1B
| $5.92M | 0.86% |
72,961
+4,301
|
|
||
11
Axsome Therapeutics
AXSM
$8.38B
| $5.64M | 0.82% |
46,456
+4,925
|
|
||
12
Pharvaris
PHVS
$1.84B
| $4.86M | 0.71% |
194,612
+6,512
|
|
||
13
Scholar Rock
SRRK
$4.52B
| $4.39M | 0.64% |
117,882
+14,400
|
|
||
|
TECX
14
Tectonic Therapeutic
TECX
$439M
| $3.82M | 0.56% |
243,728
+14,896
|
|
||
15
Amylyx Pharmaceuticals
AMLX
$1.67B
| $3.51M | 0.51% |
258,242
+39,492
|
|
||
|
MBX
16
MBX Biosciences
MBX
$1.46B
| $3.11M | 0.45% |
+177,840
|
|
||
17
Immunovant
IMVT
$5.64B
| $3.04M | 0.44% |
188,379
+40,562
|
|
||
18
Dyne Therapeutics
DYN
$2.57B
| $2.82M | 0.41% |
223,181
+84,806
|
|
||
|
19
Arrowhead Research
ARWR
$8.86B
| $2.82M | 0.41% |
+81,841
|
|
||
20
Alkermes
ALKS
$4.97B
| $2.69M | 0.39% |
89,612
+73,980
|
|
||
|
ABVX
21
Abivax
ABVX
$9.59B
| $2.55M | 0.37% |
+30,000
|
|
||
22
Snowflake
SNOW
$57.6B
| $2.26M | 0.33% |
10,000
|
|
||
23
Acadia Pharmaceuticals
ACAD
$4.16B
| $1.84M | 0.27% |
86,071
-75,325
|
|
||
24
Hudbay
HBM
$11.2B
| $1.78M | 0.26% |
117,500
+10,500
|
|
||
25
Cameco
CCJ
$51.6B
| $1.34M | 0.2% |
16,015
-3,265
|
|